
Empowering Clinicians with Comprehensive Drug Testing and Data Insights
Millennium Health is an accredited specialty laboratory with over 15 years of experience in drug testing services helping clinicians monitor use of prescription medications and illicit drugs and effectiveness of treatment plans.
Our Commitment to Clinical Excellence
Processing over a million specimens each year allows us to provide real-time analytics regarding emerging drug use trends, such as our studies published in JAMA Network Open and the Millennium Health Signals Report™ and has resulted in our collaboration with the U.S. Department of Health and Human Services to help fight our nation’s drug overdose crisis.
Urine Drug Testing
Our urine drug testing services allow for definitive detection of more than 100 drugs and metabolites encompassing over 400 brand name drugs.
Oral Fluid Drug Testing
Oral fluid drug testing (OFT) is a convenient alternative to urine drug testing.
Platform for
Test Management
Intellium leverages proprietary data intelligence and clinical expertise to help clinicians improve patient care.

Michael’s Story
“We consider drug testing a crucial component of the work that we do and with Millennium Health, it is like we are family.”
READ MORE →
LATEST NEWS
Millennium Health
in the News


JAMA Network Open Study
JAMA Network Open Study

UnitedHealthcare Preferred Lab Network
UnitedHealthcare Preferred Lab Network

Carfentanil Extends Deadly Reach
Carfentanil Extends Deadly Reach

Interpreting Low-Level EtG
Interpreting Low-Level EtG

Signals Alert: Xylazine
Signals Alert: Xylazine

Signals Alert: Alcohol
Signals Alert: Alcohol

Methamphetamine Use in Arizona
Methamphetamine Use in Arizona

Methamphetamine Use in California
Methamphetamine Use in California

Methamphetamine Use in Washington
Methamphetamine Use in Washington

2023 Recap
2023 Recap

Signals Report Volume 6
Signals Report Volume 6

Millennium Health in the News
Millennium Health in the News

Signals Alert: Carfentanil
Signals Alert: Carfentanil

Signals Report: Xylazine
Signals Report: Xylazine

Signals Alert: Parafluorofentanyl
Signals Alert: Parafluorofentanyl

Fentanyl Awareness Event
Fentanyl Awareness Event

What You Should Know About Xylazine
What You Should Know About Xylazine

Presentation at CPDD
Presentation at CPDD

JAMA Psychiatry Study
JAMA Psychiatry Study

Signals Report Vol. 5
Signals Report Vol. 5

CDC Collaboration
CDC Collaboration

Arizona: Increase in Fentanyl Exposure
Arizona: Increase in Fentanyl Exposure

Minnesota: Increase in Fentanyl Exposure
Minnesota: Increase in Fentanyl Exposure

Washington: Increase in Fentanyl Use
Washington: Increase in Fentanyl Use

PAINWeek 2022 Poster
PAINWeek 2022 Poster

Journal of Opioid Management Study
Journal of Opioid Management Study

UnitedHealthcare Preferred Lab Network
UnitedHealthcare Preferred Lab Network

HITRUST Recertification
HITRUST Recertification

Millennium UDT Update
Millennium UDT Update

JAMA Study with OSU
JAMA Study with OSU

NIDA-Funded Research with UC
NIDA-Funded Research with UC

Oregon: Increase in Fentanyl Use
Oregon: Increase in Fentanyl Use

Dr. Passik | BOD for IHFDA
Dr. Passik | BOD for IHFDA

Signals Report Volume 4
Signals Report Volume 4

2021 Clinical Recap
2021 Clinical Recap

Welcome CEO Scott Walton
Welcome CEO Scott Walton

Alcohol Study
Alcohol Study

Dr. Passik Joins the Team
Dr. Passik Joins the Team

Buprenorphine Study in JAMA
Buprenorphine Study in JAMA

Columbia University Agreement
Columbia University Agreement

OFT Expansion
OFT Expansion

Signals Report Vol. 3
Signals Report Vol. 3

Methamphetamine Positivity Increase
Methamphetamine Positivity Increase

Study: Fentanyl Analog Positivity
Study: Fentanyl Analog Positivity

Co-Authored Study with HHS in JAMA
Co-Authored Study with HHS in JAMA

Ohio Department of Public Safety Collaboration
Ohio Department of Public Safety Collaboration

Signals Report COVID-19 Special Edition
Signals Report COVID-19 Special Edition

UnitedHealthcare Preferred Lab Network
UnitedHealthcare Preferred Lab Network

Signals Report, Volume 2
Signals Report, Volume 2

Collaboration with the HHS
Collaboration with the HHS

JAMA Network Open Study
JAMA Network Open Study

Millennium Health Named One of the 50 Most Trustworthy Companies
Millennium Health Named One of the 50 Most Trustworthy Companies

Millennium Health Fentanyl Test Offering Expanded to Address Latest DEA Emerging Threat Report
Millennium Health Fentanyl Test Offering Expanded to Address Latest DEA Emerging Threat Report

Nation Experiencing an Increase in Rate of Fentanyl Positivity Among Urine Drug Tests Also Positive for Cocaine or Methamphetamine, According to JAMA Network Open Study
Nation Experiencing an Increase in Rate of Fentanyl Positivity Among Urine Drug Tests Also Positive for Cocaine or Methamphetamine, According to JAMA Network Open Study

Millennium Health’s Signals Report™ Identifies Regional and Historical Trends Regarding Prescription and Illicit Drug Use in the United States
Millennium Health’s Signals Report™ Identifies Regional and Historical Trends Regarding Prescription and Illicit Drug Use in the United States
Careers
We are constantly seeking talented individuals who will help us provide rapid and reliable healthcare solutions that our employees take pride in, patients and clinicians trust, and payers value.



Contact Us
Customer Service
(RADAR® Hotline)
(866) 866-0605
customerservice@millenniumhealth.com
Monday–Friday 5:00AM-5:30PM PT